![Bradley Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Campbell
President at
Scioderm, Inc.
Profile
Bradley Lewis Campbell holds the position of President, Chief Operating Officer & Director at Amicus Therapeutics, Inc. Mr. Campbell is also on the board of BioNJ, Inc., Alliance for Regenerative Medicine, Amicus Therapeutics UK Ltd. and New Jersey Health Initiatives. In the past Mr. Campbell occupied the position of Business Director-Cardiac Gene Therapy Programs at Genzyme Corp. and Director at National Tay-Sachs & Allied Diseases Association. He received an undergraduate degree from Duke University and an MBA from Harvard Business School.
Bradley Campbell active positions
| Companies | Position | Start |
|---|---|---|
New Jersey Health Initiatives | Director/Board Member | - |
Amicus Therapeutics UK Ltd.
 Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director/Board Member | - |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | President | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Former positions of Bradley Campbell
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Chief Executive Officer | 2026-04-26 |
| PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 2020-06-18 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 2005-12-31 |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Director/Board Member | - |
| ARYA SCIENCES ACQUISITION III A | Director/Board Member | - |
Training of Bradley Campbell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
National Tay-Sachs & Allied Diseases Association
 National Tay-Sachs & Allied Diseases Association Miscellaneous Commercial ServicesCommercial Services Operates as an association for providing funding, research, and support services for individual affected with Tay-Sachs, Canavan, Sandhoff, GM1 gangliosidosis, and related diseases | Commercial Services |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
New Jersey Health Initiatives | |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
- Stock Market
- Insiders
- Bradley Campbell
